Hepatitis C Virus E1E2 co-evolving networks unveil their functional dialogs and highlight original therapeutic strategies

Hepatitis C Virus (HCV) infects more than 170 million people worldwide but no vaccine is available yet. HCV entry may represent a promising target for therapies and is mediated by two envelope glycoproteins, E1 and E2, assembled as heterodimer onto the virus surface. However, how E1 and E2 dialog, s...

Full description

Bibliographic Details
Main Author: Douam, Florian
Language:ENG
Published: Ecole normale supérieure de lyon - ENS LYON 2013
Subjects:
Online Access:http://tel.archives-ouvertes.fr/tel-00946592
http://tel.archives-ouvertes.fr/docs/00/94/65/92/PDF/DOUAM_Florian_2013_These_VD.pdf